Amani Therapeutics
Amani Therapeutics
Developing highly efficacious, safer medicines.
About
What does Amani Therapeutics do?
Amani Therapeutics is a biotechnology company focused on developing highly efficacious, safer medicines for people living with various conditions. The company was founded with backing from RTW Investments and has in-licensed a Phase 3-ready novel chemical entity (NCE) from AstraZeneca as part of its lead program, AM-01.
What is Amani Therapeutics's revenue?
StartupHub estimates Amani Therapeutics's annual revenue at $3.2M (range $632K to $9.0M, 35% confidence), based on comparable companies in the sector.
What is Amani Therapeutics's valuation?
StartupHub estimates Amani Therapeutics's effective valuation at $101.5M (range $62.5M to $150.0M, 23% confidence), based on comparable companies in the sector.
How much funding has Amani Therapeutics raised?
Amani Therapeutics has raised a total of $25M in funding. The most recent round on record is Series A.
Where is Amani Therapeutics headquartered?
Amani Therapeutics is headquartered in New York, USA.
What industry does Amani Therapeutics operate in?
Amani Therapeutics operates in Biotechnology, Pharmaceuticals, Healthcare.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.